Notably, the effects of EHMT2 inactivation on KrasG12D-induced growth remained under pancreatitis-stimulated conditions, providing further evidence that targeting this epigenomic regulator exerts a dominant effect over the functions of this oncogene. Here, EHMT2 is linked to pancreatitis.